[3cmU-~Il/04/V2013 The invention relates to polymorphic crystal modifications of 1-((4-methyl-quinazolin-2 yl)methvl)-3,7-(2-butyn-lvl)-8-(3-(R)-aminopiperidin-1I -yl)xanthine, their production and their use for the preparation of a drug.
申请公布号
AU2013203622(A1)
申请公布日期
2013.05.02
申请号
AU20130203622
申请日期
2013.04.11
申请人
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
发明人
KEMMER, DIRK;RENZ, MARTIN;NICOLA, THOMAS;SIEGER, PETER;KOHLBAUER, PETER
